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Abstract: Three-dimensional (3D) cell culture is a major focus of current research, since cultivation
under physiological conditions provides more reliable information about in vivo cell behavior. 3D cell
cultures are used in basic research to better understand intercellular and cell-matrix interactions.
Moreover, 3D cell culture plays an increasingly important role in the in vitro testing of bioactive
substances and tissue engineering. Gelatin-methacryloyl (GelMA) hydrogels of different degrees
of functionalization (DoFs) are a versatile tool for 3D cell culture and related applications such
as bioprinting. Human platelet lysate (hPL) has already demonstrated positive effects on 2D
cell cultures of different cell types and has proven a valuable alternative to fetal calf serum
(FCS). Traditionally, all hydrogels are formulated using buffers. In this study, we supplemented
GelMA hydrogels of different DoF with hPL during adipose tissue-derived mesenchymal stem
cell (AD-MSCs) encapsulation. We studied the effect of hPL supplementation on the spreading,
proliferation, and osteogenic differentiation of AD-MSCs. In addition, the influence of hPL on
hydrogel properties was also investigated. We demonstrate that the addition of hPL enhanced
AD-MSC spreading, proliferation, and osteogenic differentiation in a concentration-dependent
manner. Moreover, the addition of hPL also increased GelMA viscosity and stiffness.
Keywords: gelatin-methacryloyl (GelMA); hydrogels; 3D cell culture; human platelet lysate; adipose
tissue-derived mesenchymal stem cells (AD-MSCs)
1. Introduction
Three-dimensional (3D) cell culture systems provide a more physiological environment for cells
in comparison to traditional 2D cell cultures in terms of cell-cell and cell-matrix interactions and
diffusion behavior. Indeed, in 2D cell cultures, signaling molecules released by cells are immediately
diluted in the greater volume of the cell culture medium instead of acting in a concentration- and
site-dependent manner on other cells. Moreover, no physiological gradients of signaling molecules,
metabolites, and oxygen can be created in 2D culture systems. For these reasons, 3D cultures are now
increasingly used in basic research, drug screening, toxicity studies, and tissue engineering (TE) [1–4].
There are several 3D cell culture models that are used for these applications: scaffold-free cellular
aggregates, cells growing on natural or synthetic scaffolds, and cells encapsulated in hydrogels [5,6].
The latter have become highly popular, since hydrogels can be made of a great variety of synthetic and
natural molecules, and their properties can be adjusted according to cell model requirements [7–9].
Among others, gelatin-methacryloyl (GelMA) provides a broad spectrum of tunable parameters,
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which lead to the creation of hydrogel networks with different stiffness and pore architectures [10–13].
Thus, these hydrogels can serve as a versatile platform for 3D cell culture research and TE. Mesenchymal
stem cells (MSCs) are widely used in biomedical applications. These include the use of MSCs in
cell therapies for different indications and as part of TE constructs. Although cell therapies using
MSCs are currently involved in over 900 clinical trials, the field of tissue engineering is still under
development [14]. One of the challenges in this case is the development of suitable scaffolds. In the
case of soft tissues, decellularized human tissues could be used as a TE scaffold. This strategy,
however, has several limitations, such as possible rejection in case of allogenic transplantation [15,16].
Thus, engineered polymers like hydrogels represent a valuable alternative to decellularized tissues.
On the one hand, the cultivation of cells in 3D systems recapitulates the in vivo microenvironment
and diffusion rates in a better manner. On the other hand, slower diffusion rates can slow down cell
adhesion and nutrient supply. Indeed, in comparison to 2D cell cultures, cell adhesion in hydrogels
is much slower [17]. One reason for this observation could be that cell-containing constructs are
traditionally formulated from hydrogels reconstituted in buffers (e.g., in phosphate buffer saline (PBS)).
Even if the hydrogels in question possess enough arginine-glycine-aspartic acid (RGD) motifs for focal
adhesion, typical adhesion proteins like fibronectin are still missing inside the bulk hydrogel and need
to diffuse from the media into the hydrogel to exert their effects.
Existing studies have shown that human platelet lysate (hPL) provides cells cultivated in vitro with
numerous growth factors and small molecules required for growth and proliferation [18–28]. hPL increases
cell proliferation and differentiation in 2D and can be used as a xeno-free supplement for various types of
primary cells, including MSCs [18,19,22–30]. hPL can be easily produced from human platelet concentrate
in conformity with good manufacturing practice (GMP) guidelines [28]. Thus, hPL appears to be a
valuable alternative to FCS. Moreover, the application of hPL complies with modern social principles of
ethics, sustainability, recycling, and conservation of resources. Platelets are donated worldwide within the
scope of blood donation campaigns, though more than twenty percent of donated platelets expire before
they can be used for infusions, due to their short shelf life. Since no differences were detected between the
use of hPL prepared from expired or fresh platelet concentrates as a medium supplement, it is possible
and desirable to recycle expired platelets obtained from blood banks [31].
In the present study, we hypothesized that the formulation of GelMA hydrogels with hPL will be
beneficial for MSCs in terms of cell spreading, proliferation, and osteogenic differentiation. The effect
of hPL addition on the mechanical properties of GelMA has also not been studied yet. In this work,
we investigated (1) the influence of hPL on MSCs cultivated in hydrogels and (2) the influence of hPL
on hydrogel viscosity and stiffness.
2. Materials and Methods
2.1. GelMA Synthesis and Hydrogel Preparation
GelMA of different degrees of functionalization (DoF) (50%, 70%, and 95%) was synthesized
and analyzed as described earlier [10]. GelMA solutions were prepared at a concentration of 5%
(w/v) by weighing an appropriate amount of GelMA and dissolving it in phosphate-buffered saline
(PBS, pH 7.4), in PBS with the addition of 2.5%, 50% hPL (% v/v), or by 100% hPL (hPL pH value 7.3,
manufactured by German Red Cross, Blood Service NSTOB, Springe, Germany). The GelMA solutions
were incubated in a water bath until complete dissolution of the solid GelMA at 37 ◦C. All GelMA
solutions contained 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (Irgacure 2959) at a final
concentration of 0.1% (w/v). Warm GelMA solutions were sterile filtered prior to cell experiments
using 0.45-µm polyethersulfone (PES) filters under aseptic conditions.
2.2. Rheological Characterization
GelMA viscosity was determined at 20 ◦C and 37 ◦C by rotational viscosimetry using an MCR
302 modular rheometer (Anton Paar, Graz, Austria) equipped with a plate-plate geometry (20-mm
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plate diameter) and a gap size of 1 mm. The shear rate was varied from 0.1–1000 s−1, which is a typical
shear rate region associated with pneumonic extrusion bioprinting.
The storage modulus of GelMA hydrogels with and without the addition of hPL was investigated
in situ at 25 ◦C using an MCR 302 modular rheometer (Anton Paar, Graz, Austria) equipped with
a plate-plate geometry (20-mm diameter, 1-mm gap size). The sample volume of 360 µL of GelMA
with 0.1% (w/v) photoinitiator (PI) was filled in between the gap and was polymerized by performing
in situ UV cross-linking by irradiation with a UV lamp (Delolux 80, Delo, Windach, Germany) from
below, with a UV intensity of 20 mW/cm2 and UV irradiation time of 5 min. The storage modulus was
recorded with a time sweep oscillatory test under a constant strain amplitude of 1% and at a constant
frequency of 1 Hz, which is within the linear viscoelastic (LVE) region. The parent gelatin material was
dissolved, and a sample volume of 400 µL was filled in silicon molds (20-mm diameter) and solidified
for an hour at room temperature. The solid construct was placed in the rheometer, and the storage
modulus was recorded with a time sweep oscillatory test.
2.3. Hydrogel Swelling
Polymerized GelMA hydrogels were incubated in water until equilibrium and weighed.
The hydrogels were then frozen over night at −80 ◦C and lyophilized. The weight of the hydrogels after
freeze-drying was also determined. The swelling ratio can be calculated from the weight after swelling
(WS) and the weight of the dry hydrogel after lyophilization (WD) according to the following formula [32]:
Swelling ratio =
(WS −WD)
WD
2.4. Cell Culture
Human adipose tissue-derived mesenchymal stem cells (AD-MSCs) were isolated from adipose
tissue after abdominoplasty. All patients provided their informed consent, as approved by the Institutional
Review Board (Hannover Medical School) with the reference number 3475-2017. The isolated cell
populations were characterized as mesenchymal stem cells by surface marker analysis, differentiation
capacity, and functional properties [10]. Cells were expanded in alpha-MEM medium (Thermo Fisher
Scientific, Waltham, MA, Germany) containing 1 g/L glucose, 2 mM·L-glutamine, 10% human serum
(HS) (CC-pro, Oberdorla, Germany), and 50 µg/mL gentamicin (Merck Millipore, Darmstadt, Germany),
harvested by accutase treatment (Merck KGaA, Darmstadt, Germany) and cryopreserved at Passage 1
until the start of the experiments. The experiments were performed with cells of Passages 2–8 only.
2.5. Encapsulation and Cultivation of AD-MSCs in Hydrogels
AD-MSCs were encapsulated in GelMA hydrogels at a concentration of 1.0 × 106 cells/mL in
50-µL disks (6-mm diameter) in silicon molds with the help of a cross linker (BLX-365 Bio-Link,
365 nm, Vilber Lourmat, Germany)) with a UV intensity of 1.2 J/cm2 and a polymerization time
of approximately 5 min. Polymerized hydrogel constructs with cells were incubated in 24-well
plates in 400 µL of alpha-MEM medium (Thermo Fisher Scientific, Waltham, MA, Germany)
containing 1 g/L glucose, 2 mM L-glutamine, 10% HS (CC-pro, Oberdorla, Germany), and 50 µg/mL
gentamicin (Merck Millipore, Darmstadt, Germany). To avoid cell adhesion on the well bottoms,
1% agarose coating of wells was performed before cultivation. Hydrogel constructs with cells were
cultivated in a humidified atmosphere containing 5% CO2 and 21% O2 at 37 ◦C. Indirect cell viability
was estimated by the CellTiter-Blue® (CTB) assay according to the manufacturer’s instructions
(Promega, Mannheim, Germany). Briefly, CTB stock solution was added to the medium of the cells
to receive a concentration of 10% CTB solution (1:10 v/v). After 5 h of incubation, fluorescence was
measured at an extinction wavelength of 544 nm and an emission wavelength of 590 nm using a
microplate reader (Fluoroskan Ascent, Thermo Fisher Scientific Inc., Waltham, MA, USA). Encapsulated
AD-MSCs cultivated for one, three, or seven days were incubated in 4 µM calcein-acetoxymethyl (AM)
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(Merck, Darmstadt, Germany) solution in basal alpha-MEM for 40 min at 37 ◦C and analyzed with a
Cytation 5-Cell Imaging Multi-Mode Reader (Biotek Instruments, Winooski, VT, USA).
2.6. Osteogenic Differentiation, Cryosections, and Alizarin Red Staining
AD-MSCs encapsulated in hydrogels with and without hPL were differentiated into osteoblasts.
The osteogenic differentiation medium contained 5 mM β-glycerophosphate, 0.1 µM dexamethasone,
0.2 mM L-ascorbate-2-phosphate, 0.5% gentamicin, as well as 10% HS. The medium was exchanged
every 3–4 days. Cells in hydrogels were cultured for 7, 14, or 21 days and then washed in PBS and
fixed for 15 min at 4 ◦C with 4% paraformaldehyde (Merck, Darmstadt, Germany). Fixed hydrogels
were embedded and frozen at −20 ◦C in Tissue-Tek® O.C.T.™ Compound (Sakura Finetek Europe B.V.,
Alphen aan den Rijn, The Netherlands) for cryostat sectioning. Twelve-micrometer cryosections were
made with the help of a Microm HM 560 cryostat (Thermo Fisher Scientific Inc., Waltham, MA, USA)
at −20 ◦C and mounted on Super Frost glass slides (Thermo Fisher Scientific Inc., Waltham, MA, USA).
For the evaluation of osteogenic differentiation, cryosections were incubated in Alizarin Red solution,
containing 1% Alizarin Red S (Merck KGaA, Darmstadt, Germany) in deionized H2O, for 15 min at
room temperature. After washing with deionized H2O, the red chelates were detected and analyzed
with a fluorescent microscope (Olympus, IX50, Olympus Corporation, Tokyo, Japan), equipped with a
camera (Olympus SC30, IX-TVAD, Olympus Corporation, Tokyo, Japan) and the CellSens Software
(CellSens Standard 1.7.1, Olympus Corporation, Tokyo, Japan).
3. Results
3.1. AD-MSCs’ Viability in GelMA-Hydrogels
To evaluate the influence of hPL on 3D-cultivated AD-MSCs, cells were encapsulated in three
different GelMA-hydrogels of 50%, 70%, and 95% DoF. Polymerization was performed at an intensity of
1.2 J/cm2, which has been shown to promote MSC spreading [10]. Each GelMA solution was prepared
in PBS with the addition of 0%, 2.5%, or 50% hPL (% v/v) or by adding hPL only (100% hPL), prior to the
addition of the photoinitiator and the polymerization of the hydrogels. The specific hPL concentrations
used in this study were selected because: (1) 2.5% hPL is the recommended concentration for 2D cell
cultivation [33,34]; (2) 100% represents a complete substitution of PBS with hPL; (3) 50% hPL serves as
an intermediate point between 2.5% and 100% hPL; and (4) 0% hPL functions as a control. Calcein-AM
staining was performed to evaluate the influence of hPL addition on cell viability and spreading.
Cell proliferation in hydrogels was evaluated using a CTB assay.
As shown in Figure 1, the calcein-AM staining indicated the presence of viable cells in all tested
GelMA hydrogels. In comparison to cultivation in hPL-free materials, AD-MSCs demonstrated
increased cell spreading and growth when cultivated in GelMA hydrogels containing hPL. Single cell
spreading was detectable already one day after encapsulation of AD-MSCs in the lowest functionalized
GelMA (50% DoF) formulated in hPL (100%) (Figure 1A). Cell spreading of AD-MSCs in GelMA
hydrogels typically occurred after three days of cultivation [10]. In a similar manner, the AD-MSCs
cultivated in hPL-free GelMA (hydrogels with 50% and 70% functionalization) showed only a few
spreading cells after three days of cultivation (Figure 1A,B). A positive effect of adding hPL to GelMA
could be seen by comparing the cell morphology in 0, 2.5, 50, and 100% hPL containing GelMA
hydrogels on Day 7. The higher the hPL concentration, the more cells could spread and establish
cell-cell contacts. AD-MSCs cultured in 100% hPL containing GelMA-hydrogels showed extensive
cell-cell contacts and a pronounced three-dimensional network of cells. In contrast, AD-MSCs cultivated
in GelMA hydrogels with a high DoF of 95% displayed a round morphology (Figure 1C). These cells
exhibited no spreading or cell-cell contacts over the entire cultivation period. The only exceptions
to this observation were cells cultivated in GelMA containing 50% hPL. Under these conditions, a
few cells spread within the first 24 h and showed extensive cell spreading and three-dimensional cell
growth after seven days of cultivation. Moreover, it was also noticeable that cell aggregates formed in
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hydrogels with 0% and 2.5% hPL after three and seven days, respectively. This is even more evident
by comparing the images of the entire hydrogel (Figure A1). Since cells did not sufficiently spread
and create cell-cell contacts in 95% DoF GelMA hydrogels, we excluded this material from further
investigations of osteogenic differentiation.
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Figure 1. Morphological examinati f - s encapsulated with a UV dose of 1.2 J/cm2 in 5%
GelMA with (A) 50% degree of functio alizatio ( oF), (B) 70% DoF, and (C) 95% DoF, formulated
with 0, 2.5, 50, and 100% human platelet lysate (hPL). After cultivation of 1, 3, and 7 days, the cells
were stained with calcein-AM; 4× objective, scale bar 1000 µm.
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In addition to the calcein-AM staining, a CTB assay was performed to estimate the viability of the
cells after one, three, and seven days of cultivation in GelMA hydrogels with 50%, 70%, and 95% of
functionalization. As can be seen in Figure 2, a higher hPL concentration in the GelMA led to higher
cell viability, at least on Day 7 of cultivation. Contrary to GelMA with DoF of 50% and 70%, cell
viability in 95% DoF GelMA-hydrogels was increased until the third day by the addition of 50% and
100% hPL. These results suggest that platelet lysate contributes to the preservation and enhancement
of cell viability.
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(A) 50% DoF, (B) 70% DoF, and (C) 95% DoF, dissolved in 0, 2.5, 50, and 100% hPL. The CellTiter-Blue®
(CTB) assay was performed on ay 1, Day 3, and Day 7 of cultivation. Data represent the mean ± SD
for a threefold determination.
As shown before by Pepelanova et al., AD-MSCs cultivated in GelMA with a DoF of 70% or above
were not able to spread and to est blish cell-cell contacts [10]. The addition of hPL to GelMA, however,
increased cell viability, supported cell spreading, and led to the formation of three-dimensional networks.
The increased proliferation and v ability can be attributed to growth factors contained in platelet lysate,
such as epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), platelet-derived growth
factor (PDGF), and vascular endothelial growth factor (VEGF) [27]. Improved cell spreading afte hPL
addition can be explained by the influence of proteins like vitronectin and fibronectin, which mediate
cell adhesion to the matrix [35].
3.2. AD-MSC Differentiation in GelMA-Hydrogels
In order to investigate the influence of hPL on the differentiation grade of AD-MSCs in different
GelMA hydrogels (50% nd 70% DoF), cells were cultivat d for 7, 14, and 21 days after in uctio
of osteogenic differentiation. As illustrat d in Figure 3, osteogenic differentiation of AD-MSCs was
detected by Alizari Red staining.
In contrast to 2D culture (Figure A2, the AD-MSCs’ cultivation in 3D constructs led to
an accumulation f cal ium already after on week of cultivation. Osteogenic differentiation
in 50% functionalized GelMA was more pronounced with 0% and 2.5% hPL after one week.
However, th addition of 50% and 100% hPL to GelMA showed a more hom g neous and intensive
Alizarin Red staini g in Week 3 (Figur 3A). Furthermore, G lMA with a DoF of 70% show d an increase
of differentiation in Weeks 2 and 3 in G lMA hydrogels containing 50% and 100% hPL (Figure 3B).
Thus, higher hPL conc ntratio s in hydrogels increased osteogenic differentiation of AD-MSCs. In less
functionalized hydr gels, bone nodules wer detected arlier in GelMA hydrogels f rmulated with
lower hPL concentrations, while higher f nctionalized GelMA showed increased formation of bone
nodules with higher hPL concentrations. Bone nodules are formed in vivo by prog nitor cells, which
differe tiate into osteoblasts and are thus characteristic for osteogenic differentiation [36]. A positive
effect of 3D cell cultivati n on the osteogenic differenti tion of MSCs was also demonstrated by Re et al.
in gelatin-chitosan hydrogels [9]. Our results als support the observation that 3D cultivation e hanc s
the osteogenic diff rentiation of AD-MSCs and illustrates the differentiation-supporting effect of hPL.
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Figure 3. Osteogenic differentiation of AD-MSCs encapsulated in 5% (w/v) GelMA with (A) 50% DoF
and (B) 70% DoF, formulated with 0, 2.5, 50, and 100% hPL. The GelMA-hydrogels were cryosectioned
(12 µm) and stained with Alizarin Red 7, 14, and 21 days after induction of the osteogenic differentiation;
10× objective, scale bar 100 µm.
3.3. Influence of hPL on GelMA Properties
The mechanical properties of hydrogels play an important role in cell fate and in the intended
application of these hydrogels as, e.g., bi ink for biopr nting [37]. As shown in this study, the addition
of hPL had a positive effect on spreading, proliferation, and osteogenic differentiation of AD-MSCs.
As a next step, t e influence of hPL the mechanical properties of GelMA was investigated by
measuring the viscosi y and storage modulus in rheological experiments.
The viscosity of the hydrogel s lution is crucial for the application in extrusion-based bioprinting.
On the one hand, the solution in the car ridge sy inge requires a high v scos ty so that cells do
n t precipitate before printing. High viscosi y is also d sired after pr nting in order to main ain
the printed shape before p lymerization. On the ther hand, a low viscosity is desirable at high
pressure during extru ion (sh ar thinning behavior) [38]. The viscosity of GelMA solutions (DoF 50%)
wit different concentrations of hPL was determined by varying the shear rate from 0.1–1000 s−1,
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as these shear forces typically occur during bioprinting. The viscosity was measured at 20 and 37 ◦C,
which corresponds to room temperature (e.g., during bioprinting) and the physiological cultivation
temperature. As illustrated in Figure 4, all samples showed decreasing viscosity with increasing
shear rate. Thus, GelMA showed a shear thinning flow behavior independent of hPL concentration.
Furthermore, as expected, the GelMA viscosity at 20 ◦C was higher than at 37 ◦C. More interestingly,
the addition of hPL increased GelMA viscosity in a concentration-dependent manner. This effect
was comparable to the addition of rheological additives such as hyaluronic acid, which increase the
viscosity of hydrogels [8]. These results demonstrate that the viscosity of GelMA hydrogels used as
bioinks can be adjusted by varying the concentration of hPL and the temperature used for bioprinting.
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The mechanical properties of hydrogels formulated with different hPL levels were investigated
using rheology. As can be seen in Figure 5A–C, the storage modulus of GelMA increased with higher
hPL concentrations. This effect was also observed for the parent molecule, parent gelatin material
without methacrylic modification, formulated with different hPL concentrations and measured
at 25 ◦C, where gelatin formed a physical gel (Figure 5C). At this temperature, gelatin formed
a stronger gel than the modified GelMA, whose vinyl side chains led to steric hindrance [39].
Thus, hPL addition enhanced the storage modulus of a hydrogel regardless of the type of cross-linking
involved (covalent photo-cross-linking or physical interactions). Apparently, the presence of additional
polypeptides and macromolecules in hPL contributes to the overall viscoelastic strength of the polymer
network. Similar effects were observed for rheological additives based on polysaccharides or proteins
in bioinks, as well as on the presence of protein additives like whey protein on gelatin gels [40,41].
Moreover, during the time-sweep studies of GelMA polymerization, we could also observe that higher
levels of hPL led to quicker onset of polymerization.
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Hydrogels can maintain more than 90% water in their 3D network. The extent of water uptake
influences the mechanical properties of a hydrogel such as overall elasticity, compressibility, and, thus,
ultimately, cell behavior [12,42,43]. For this reason, it was important to investigate the influence of hPL
on the swelling ratio of GelMA hydrogels. As can be seen in Figure 6, the swelling ratio decreased
with increasing hPL concentration in all teste hydrogels. Incorporating hPL in the GelMA hydrogel
decreased overall water uptake by the network. A lower swelling ratio typically indicates a more
compact network structure with smaller pores, for example resulting due to the formation of additional
cross-links. While hPL did not directly introduce more covalent cross-links into the GelMA hydrogel,
the presence of hPL macromolecules reduced available interstitial volume. Another beneficial effect of
a lower swelling ratio is improved maintenance of shape fidelity after bioprinting.
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Taken together, these results show that the addition of hPL to GelMA not only contributed to the
biological effects on the cells, but also influenced the resulting material properties of the hydrogel.
Bioengineering 2019, 6, 76 10 of 16
4. Discussion
In this study, the influence of hPL on the cell behavior of 3D cell cultures of AD-MSCs in GelMA
hydrogels was investigated. In addition, the material properties of the resulting GelMA hydrogels were
studied, as well. Since hPL had already shown a positive effect on the growth of different types of primary
and stem cells in 2D [18,21–23,25,26,29,31,44,45], we hypothesized that the addition of hPL during
hydrogel formulation would be beneficial for cells growing in 3D cultures. Moreover, the influence
of hPL on GelMA material properties in terms of viscosity (before polymerization), storage modulus
(after polymerization) and swelling ratio (after polymerization) was also previously unknown.
Cultivation of MSCs in 3D seems to be advantageous, since the quality of cells (in terms of production
of angiogenic and immunomodulatory factors) from 3D cultures is higher compared to 2D-expanded
cells [46–51]. Moreover, physiological cell-cell and cell-matrix interactions can only be recreated in 3D
cell cultures [49,52,53]. Earlier, we demonstrated that GelMA hydrogels of different DoFs can be tuned
to change their mechanical properties (e.g., UV intensity and hydrogel concentration), which in turn
influences MSC growth and behavior [10].
Traditionally, PBS or other buffer solutions are used to formulate or reconstitute
hydrogels [8,32,54–58]. In our work, we substituted PBS partially or fully with hPL. The addition of hPL
led to a concentration-dependent increase in cell viability and osteogenic differentiation. When cells
were encapsulated in hydrogels formulated with PBS only, important nutrients and adhesion factors,
which are missing in the bulk hydrogel, must diffuse from the cultivation media or be gradually
produced by the cells themselves. Kaemmerer et al. measured the diffusion rate of a 70-kDa molecule
in GelMA of DoF 70% [39]. The authors could show that the diffusion of the test molecule inside the
hydrogel construct was 23.4 µm2/s and that it was slower than diffusion in water alone. hPL contains
molecules of a great variety of sizes (e.g., fibronectin = 440 kDa), so the exact diffusion rate of all
proteins cannot be determined. In addition, the phase boundary between gel and liquid medium
represents an additional diffusion barrier. As a natural derivative from collagen I, GelMA provides
sufficient arginine-glycine-aspartic acid (RGD) sequences for cell adhesion [59–63]. The presence
of natural RGD sequences in GelMA leads to cell adhesion and spreading of encapsulated cells
typically after three days of cultivation, as shown by our group [10] and other researchers [12].
In contrast, adhesion to the plastic cell culture plate occurred after 24 h in 2D. In situ formulation
of hydrogels with hPL leads to cell attachment and spreading only after one day of cultivation in
3D. One possible explanation for this observation is the presence of vitronectin and fibronectin in
hPL. Indeed, the α-granules of platelets contain different types of adhesion proteins, including von
Willebrand factor (vWF), fibronectin, vitronectin, and thrombospondin [35,64–66]. The exact reasons
for the positive hPL effects on cell adhesion and spreading in hydrogels must be investigated in greater
detail in future studies. Fast and effective cell adhesion and spreading are extremely important for
anchorage-dependent cells like MSCs [67], since adhesion and spreading regulate their proliferation,
migration, and differentiation [67–69].
Thus, the supplementation of hydrogels with hPL directly during encapsulation and
polymerization can positively influence the cells via both (I) the provision of growth and differentiation
factors and (II) the enhancement of cell spreading and adhesion in the hydrogel. This is essential
for fast ex vivo tissue formation. Moreover, both autologous and allogenic hPL can be used for
hydrogel supplementation, which creates the possibility of individualized off-the-shelf TE constructs.
The positive effect of hPL addition to the cell culture medium during cultivation of 3D cell cultures
was also recently supported by the studies of Re et al. [9]. This group also found that the addition
of 5% hPL to the medium increased the proliferation and osteogenic differentiation of bone marrow
(BM)- and AD-MSCs encapsulated in gelatin-chitosan hybrid hydrogels [9]. Only three different
hPL concentrations (2.5%, 50%, and 100%) were investigated to study the general outcome of PBS
substitution during GelMA formulation. Further experiments, using hPL concentrations at levels
between tested ones, could lead to even better protocols. Moreover, the influence of hPL addition
on other cell types must be studied as well. In future experiments, the combination of the use of
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hPL for hydrogel formulation and for cell culture medium supplementation during expansion (2D)
and subsequent cultivation in 3D must be also studied, since such a combined protocol could further
enhance cell growth and differentiation. In our work, we demonstrated for the first time that the
addition of hPL directly to the hydrogels during formulation and polymerization displayed positive
effects on AD-MSCs.
Cell behavior and especially cell fate are directly related to the stiffness of matrix materials [70–75].
Thus, soft tissue supports the differentiation of stem cells into neural lineages, while stiffer materials
support the differentiation into muscle cells. Finally, hard and rigid materials lead to osteogenic
differentiation [70–75]. In this study, three GelMA materials with different degrees of functionalization
and thus, stiffness, were used to study the effect on cell growth. A material of 50% DoF was compared
to a material of higher mechanical strength (70% DoF). Indeed, we could show that a higher degree of
osteogenic differentiation was achieved at the higher DoF and thus at higher mechanical strengths.
Moreover, the addition of hPL was shown to contribute to an increase in the overall mechanical strength
of the material, which also promoted osteogenic differentiation.
3D bioprinting represents an advanced 3D cell culture technique, where higher spatial control of
cell distribution/organization can be achieved. Earlier, we reported that GelMA hydrogels can be used
for bioprinting, but that such bioinks would require viscosity enhancers for printing at the low GelMA
concentrations supporting AD-MSCs cell spreading [10]. The results of the current work demonstrate
that supplementation with hPL alone increases hydrogel viscosity at room temperature, which in
turn makes hPL an interesting addition to the bioink toolkit. However, even higher viscosities are
usually required for high fidelity extrusion bioprinting [76]. In our lab, we typically use viscosities
between 20 and 200 mPa·s for the bioprinting of cell-promoting bioinks. This viscosity range, however,
will necessitate the addition of rheological additives or even lower printing temperatures during
bioprinting of hPL-formulated GelMA. As an additional effect, hPL decreases the swelling ratio of
the hydrogel, which is beneficial for maintaining shape fidelity after printing. Of course, the true
printability of GelMA hydrogels formulated with hPL has to be evaluated in future studies.
Taken together, our results demonstrated that the supplementation of GelMA hydrogels with
different degrees of functionalization with hPL had a positive effect on cell spreading, proliferation,
and differentiation. Moreover, the viscosity of GelMA solutions and the storage modulus of
cross-linked hydrogels were increased by the addition of hPL. These results can be used to improve
the protocols/methods for hydrogel-based tissue engineering and for extrusion-based bioprinting.
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Figure A1. Cell aggregation of AD-MSCs in GelMA hydrogels (95% DoF) containing 0% and 2.5% 
hPL. Fluorescence pictures taken after one, three, and seven days of cultivation (4× objective and 
combined pictures). Scale bar 2000 µm per picture. 
 
Figure A2. Osteogenic differentiation of 2D-cultivated AD-MSCs. The cells were stained with 
Alizarin Red 7, 14, and 21 days after induction of the osteogenic differentiation; 10× objective, scale 
bar 100 µm. 
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